Nucleic acid ligand diagnostic biochip
A nucleic acid ligand “biochip” is disclosed, consisting of a solid support to which one or more specific nucleic acid ligands is attached in a spatially defined manner. Each nucleic acid ligand binds specifically and avidly to a particular target molecule contained within a test mixture, such as a bodily fluid. The target molecules include, but are not limited to, proteins (cellular, viral, bacterial, etc.) hormones, sugars, metabolic byproducts, cofactor, and intermediates, drugs, and toxins. Contacting the test mixture with the biochip leads to the binding of a target molecule to its cognate nucleic acid ligand. The biochip may then be contacted with a reagent(s) that reacts covalently with proteins and not with nucleic acids. Each protein target in the test mixture may then detected by detecting the presence of the reagent at the appropriate address on the biochip.
1. A method for detecting the presence of a plurality of different target molecules suspected of being contained in a test mixture, wherein said target molecules to be detected are proteins, the method comprising:
a) providing a biochip comprising a solid support, said solid support comprising a plurality of spatially defined addresses, each said address comprising nucleic acid ligand attached thereto, each said nucleic acid ligand having specific binding affinity for one of said target molecules suspected of being contained in said test mixture, and said nucleic acid ligand being non-naturally occurring and binding specifically to said target molecule through non-Watson-Crick interactions, and not having the known physiological function of binding to the target protein;
b) contacting said biochip with said test mixture suspected of containing said target molecules;
c) removing non-specifically bound material from said biochip;
d) contacting said biochip with a reagent that is at least 8,000 fold more reactive on a mole:mole basis covalently and non-specifically with proteins than with nucleic acids, wherein said proteins are bound specifically to the nucleic acid ligands on the surface of said biochip; and
e) detecting the presence of said target molecules by detecting the presence of said reagent at the appropriate address on said biochip.
2. The method of claim 1 wherein said reagent comprises a fluorophore.
3. The method of claim 1 wherein step c) is accomplished by washing said biochip.
4. A method for detecting the presence of a plurality of different target molecules suspected of being contained in a test mixture, wherein said target molecules to be detected are proteins, the method comprising:
a) providing a biochip comprising a solid support, said solid support comprising a plurality of spatially defined addresses, each said address comprising a nucleic acid ligand attached thereto, each said nucleic acid ligand having specific binding affinity for one of said target molecules suspected of being contained in said test mixture, said nucleic acid ligands being non-naturally occurring and binding specifically to said target molecule through non-Watson-Crick interactions, and not having the known physiological function of binding to the target protein, and wherein said nucleic acid ligand having specific binding affinity for said target molecule to be detected is a photoreactive nucleic acid ligand;
b) contacting said biochip with said test mixture suspected of containing said target molecules, wherein a nucleic acid ligand-target molecule complex is formed if said target molecule is present;
c) irradiating said biochip, wherein said nucleic acid ligand-target molecule complex photocrosslinks;
d) removing non-specifically bound material from said biochip;
e) contacting said biochip with a reagent that is at least 8,000 fold more reactive on a mole:mole basis covalently and non-specifically with proteins than with nucleic acids, wherein said proteins are bound specifically to the nucleic acid ligands on the surface of said biochip; and
f) detecting the presence of said target molecules by detecting the presence of said reagent at the appropriate address on said biochip.
5. The method of claim 4 wherein said reagent comprises a fluorophore.
6. The method of claim 5 wherein the fluorophore is detected by its fluorescence emission.
7. A method for detecting the presence of a plurality of different target molecules suspected of being contained in a test mixture, wherein said target molecule is a protein, the method comprising;
a) providing a solid support, said solid support comprising a plurality of spatially defined addresses, each said address comprising a nucleic acid ligand attached thereto, each said nucleic acid ligand having specific binding affinity for said target protein, said nucleic acid ligands being non-naturally occurring and binding specifically to said target protein through non-Watson-Crick interactions, and not having the known physiological function of binding to the target protein;
b) contacting said solid support with said test mixture suspected of containing said target molecules;
c) removing non-specifically bound material from said solid support;
d) contacting said solid support with a reagent that is at least 8,000 fold more reactive on a mole:mole basis non-specifically with proteins than with nucleic acids, wherein said proteins are bound specifically to the nucleic acid ligands on the surface of said biochip; and
e) detecting the presence of said target molecules by detecting the presence of said reagent at the appropriate address on said solid support.
8. A method for detecting the presence of a plurality of different target molecules suspected of being contained in a test mixture, wherein said target molecule is a protein, the method comprising:
a) providing a solid support, said solid support comprising a plurality of spatially defined addresses, each said address comprising a photoreactive nucleic acid ligand attached thereto, each photoreactive nucleic acid ligand having specific binding affinity for said target protein, said photoreactive nucleic acid ligands being non-naturally occurring and binding specifically to said target molecule through non-Watson-Crick interactions, and not having the known physiological function of binding to the target protein;
b) contacting said solid support with said test mixture suspected of containing said target molecules, wherein a nucleic acid ligand-target molecule complex is formed if said target molecule is present;
c) irradiating said solid support, wherein said nucleic acid ligand-target molecule complex photocrosslinks;
d) removing non-specifically bound material from said solid support;
e) contacting said solid support with a reagent that is at least 8,000 fold more reactive on a mole:mole basis non-specifically with proteins than with nucleic acids, wherein said proteins are bound specifically to the nucleic acid ligands on the surface of said biochip; and
f) detecting the presence of said target molecules by detecting the presence of said reagent at the appropriate address on said solid support.